ASX:PCK

PainChek Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

PainChek (ASX:PCK) Vs. 1ST, ALC, BNVIF, CNNA, CNONF, and DOCRF

Should you be buying PCK stock or one of its competitors? Companies in the industry of "health information services" are considered alternatives and competitors to PainChek, including 1st Group (1ST), Alcidion Group (ALC), Binovi Technologies (BNVIF), Cann American (CNNA), CannaOne Technologies (CNONF), and CloudMD Software & Services (DOCRF).

1st Group (ASX:1ST) and PainChek (ASX:PCK) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends.

Earnings & Valuation

This table compares 1st Group and PainChek's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
1st Group$5.11 million0.00$-4,246,169.92A($0.01)N/A
PainChek$240,424.000.00$-4,507,200.00A$0.00N/A

1st Group has higher revenue and earnings than PainChek.

Profitability

This table compares 1st Group and PainChek's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
1st GroupN/AN/AN/A
PainChekN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings for 1st Group and PainChek, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
1st Group0000N/A
PainChek0000N/A

Summary

1st Group beats PainChek on 2 of the 3 factors compared between the two stocks.

PainChek (ASX:PCK) and Alcidion Group (ASX:ALC) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, dividends, risk, institutional ownership and earnings.

Profitability

This table compares PainChek and Alcidion Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PainChekN/AN/AN/A
Alcidion GroupN/AN/AN/A

Valuation and Earnings

This table compares PainChek and Alcidion Group's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PainChek$240,424.000.00$-4,507,200.00A$0.00N/A
Alcidion Group$21.55 million0.00$-2,972,082.05A$0.00N/A

Alcidion Group has higher revenue and earnings than PainChek.

Analyst Ratings

This is a breakdown of current recommendations and price targets for PainChek and Alcidion Group, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
PainChek0000N/A
Alcidion Group0000N/A

Summary

Alcidion Group beats PainChek on 3 of the 3 factors compared between the two stocks.

Binovi Technologies (OTCMKTS:BNVIF) and PainChek (ASX:PCK) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends and valuation.

Earnings & Valuation

This table compares Binovi Technologies and PainChek's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Binovi TechnologiesN/AN/AN/AN/AN/A
PainChek$240,424.000.00$-4,507,200.00A$0.00N/A

Binovi Technologies has higher earnings, but lower revenue than PainChek.

Analyst Recommendations

This is a summary of recent recommendations for Binovi Technologies and PainChek, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Binovi Technologies0000N/A
PainChek0000N/A

Profitability

This table compares Binovi Technologies and PainChek's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Binovi TechnologiesN/AN/AN/A
PainChekN/AN/AN/A

Summary

PainChek beats Binovi Technologies on 1 of the 1 factors compared between the two stocks.

PainChek (ASX:PCK) and Cann American (CNSX:CNNA) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, profitability, valuation, dividends and risk.

Earnings and Valuation

This table compares PainChek and Cann American's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PainChek$240,424.000.00$-4,507,200.00A$0.00N/A
Cann AmericanN/AN/AN/AN/AN/A

Cann American has lower revenue, but higher earnings than PainChek.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for PainChek and Cann American, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
PainChek0000N/A
Cann American0000N/A

Profitability

This table compares PainChek and Cann American's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PainChekN/AN/AN/A
Cann AmericanN/AN/AN/A

Summary

PainChek beats Cann American on 1 of the 1 factors compared between the two stocks.

PainChek (ASX:PCK) and CannaOne Technologies (OTCMKTS:CNONF) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, profitability, valuation, dividends and risk.

Earnings and Valuation

This table compares PainChek and CannaOne Technologies' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PainChek$240,424.000.00$-4,507,200.00A$0.00N/A
CannaOne TechnologiesN/AN/AN/AN/AN/A

CannaOne Technologies has lower revenue, but higher earnings than PainChek.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for PainChek and CannaOne Technologies, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
PainChek0000N/A
CannaOne Technologies0000N/A

Profitability

This table compares PainChek and CannaOne Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PainChekN/AN/AN/A
CannaOne TechnologiesN/AN/AN/A

Summary

PainChek beats CannaOne Technologies on 1 of the 1 factors compared between the two stocks.

PainChek (ASX:PCK) and CloudMD Software & Services (OTCMKTS:DOCRF) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, profitability, valuation, dividends and risk.

Earnings and Valuation

This table compares PainChek and CloudMD Software & Services' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PainChek$240,424.000.00$-4,507,200.00A$0.00N/A
CloudMD Software & ServicesN/AN/AN/AN/AN/A

CloudMD Software & Services has lower revenue, but higher earnings than PainChek.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for PainChek and CloudMD Software & Services, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
PainChek0000N/A
CloudMD Software & Services00203.00

CloudMD Software & Services has a consensus target price of $3.3750, indicating a potential upside of 97.37%.

Profitability

This table compares PainChek and CloudMD Software & Services' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PainChekN/AN/AN/A
CloudMD Software & ServicesN/AN/AN/A


PainChek Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
1st Group logo
1ST
1st Group
0.5N/AN/A$0.00$5.11 million0.00High Trading Volume
Gap Up
ALC
Alcidion Group
0.5N/AN/A$0.00$21.55 million0.00High Trading Volume
Gap Up
Binovi Technologies logo
BNVIF
Binovi Technologies
0.0$0.07flat$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Up
CNNA
Cann American
0.5N/AN/A$0.00N/A0.00High Trading Volume
CannaOne Technologies logo
CNONF
CannaOne Technologies
0.6$0.83flat$0.00N/A0.00Decrease in Short Interest
CloudMD Software & Services logo
DOCRF
CloudMD Software & Services
1.7$1.71flat$0.00N/A0.00Decrease in Short Interest
Gap Down
DOC
CloudMD Software & Services
1.2$2.16flatC$0.00C$11.65 million-24.00
CGS
Cogstate
0.5N/AN/A$0.00$28.82 million0.00High Trading Volume
Gap Up
COO
Corum Group
0.5N/AN/A$0.00$12.27 million0.00High Trading Volume
EGF Theramed Health logo
EVAHF
EGF Theramed Health
0.0$0.11flat$0.00N/A0.00Decrease in Short Interest
Gap Down
EMD
Emyria
0.6N/AN/A$0.00$1.73 million0.00High Trading Volume
Gap Up
EWLL
eWellness Healthcare
0.6$0.00flat$0.00N/A0.00Gap Down
FORA
Forian
0.3$12.72flat$0.00N/A0.00News Coverage
GLH
Global Health
0.5N/AN/A$0.00$6.77 million0.00High Trading Volume
Gap Up
ICS
ICS Global
0.9N/AN/A$0.00$6.08 million0.00High Trading Volume
Gap Up
JHL
Jayex Healthcare
0.7N/AN/A$0.00$6.61 million0.00High Trading Volume
Gap Up
M3 logo
MTHRF
M3
1.0$74.03flat$0.00N/A0.00News Coverage
M7T
Mach7 Technologies
0.6N/AN/A$0.00$16.89 million0.00High Trading Volume
Gap Up
MDR
MedAdvisor
0.5N/AN/A$0.00$18.09 million0.00High Trading Volume
Gap Up
NEWUF
Newtopia
1.7$0.43flat$0.00N/A0.00Gap Up
NHL
Novita Healthcare
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
ONE
Oneview Healthcare
0.5N/AN/A$0.00$7.10 million0.00High Trading Volume
OPL
Opyl
0.0N/AN/A$0.00$741,494.000.00High Trading Volume
PANHF
Ping An Healthcare and Technology
1.0$12.20flat$0.00N/A0.00News Coverage
Gap Up
PKS
PKS
0.0N/AN/A$0.00$5.97 million0.00High Trading Volume
PME
Pro Medicus
0.7N/AN/A$0.00$59.12 million0.00High Trading Volume
Gap Up
Pro Medicus logo
PMCUF
Pro Medicus
0.5$33.83flat$0.00N/A0.00Decrease in Short Interest
RAP
ResApp Health
0.9N/AN/A$0.00$46,197.000.00High Trading Volume
Gap Up
CBIIF
Skylight Health Group
0.0$0.96flat$0.00N/A0.00High Trading Volume
Gap Up
TD1
TALi Digital
0.5N/AN/A$0.00$706,550.000.00High Trading Volume
UCBB
US-China Biomedical Technology
0.3$0.13flat$0.00N/A0.00
WELL Health Technologies logo
WLYYF
WELL Health Technologies
1.6$6.06flat$0.00N/A0.00
ZMD
ZoomMed
0.4$0.02flatC$0.00C$10,000.00-1.36Gap Down
This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.